Drug Development
King Pharmaceuticals, Arrow, affiliates collaborate on new formulations of ramipril
Published in Biotech Business Week, March 13th, 2006
Under a series of agreements, Arrow has granted King rights to certain current and future New Drug Applications (NDAs) regarding the Altace formulations and intellectual property, including patent rights and technology licenses relating to them. Under certain conditions, Arrow will be responsible for the manufacture and supply of new formulations of Altace for King. Additionally, King has granted Cobalt Pharmaceuticals, Inc. a non-exclusive right to enter into the U.S....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Genetics & Genomics
Integromics has potential in biological research - HIV/AIDS Testing
HIV diagnostic changes will involve monitoring individual's progress, market study shows - Healthcare Coverage
Integrated Healthcare Association releases 5-year report on pay for performance experience - Marketing
Market entrance plays important role in commercialization spending, Cutting Edge report says - Medicare
Impact of over-65 market segment's high drug use discussed in market research report - Alzheimer Disease
Alzheimer disease may be detected with blood-based test - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
